This poster developed by Berkeley Lights and Pfizer demonstrates rapid antibody discovery on the Beacon platform, showing how it can rapidly isolate and screen thousands of primary ASCs in a single day.
Dr. Robert Carnahan, Ph.D., discusses how the Beacon system helped enable the rapid discovery functional antibodies against SARS-CoV-2.
Dr. Shireen Khan presents a case study on how ChemPartner has leveraged the Beacon system to rapidly discover cross-reactive antibodies against the GPI-anchored uPA receptor.
Explore case studies for the rapid discovery of antibodies against challenging targets.